ThermoGenesis Holdings, Inc. (THMO)

ThermoGenesis Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-14.75	-17.98	-11.27	-11.38	-16.35	-9.5
Depreciation & Amortization	1.21	1.15	0.93	0.63	0.74	0.81
Share-Based Compensation	0.04	0.04	0.27	2.56	0.88	0.61
Other Operating Activities	9.88	13.07	2.79	1.57	0.34	4.82
Operating Cash Flow	-3.61	-3.72	-7.28	-6.62	-14.39	-3.26
Capital Expenditures	-0.98	-1.73	-0.4	-0.09	-0.02	-0.18
Investing Cash Flow	-0.98	-1.73	-0.4	-0.09	-0.02	-0.18
Common Stock Issued	0.32	2.86	4.58	6.83	12.52	0.91
Other Financing Activities	-0.4	0.42	0	-	4.9	3.29
Financing Cash Flow	-0.08	3.28	4.59	6.83	17.42	4.2
Net Cash Flow	-4.68	-2.18	-3.1	0.12	3	0.76
Free Cash Flow	-4.59	-5.45	-7.68	-6.71	-14.42	-3.44
Free Cash Flow Margin	-47.79%	-57.74%	-73.29%	-72.23%	-147.95%	-26.38%
Free Cash Flow Per Share	-1.14	-2.30	-13.94	-25.61	-103.33	-54.76

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.